Inactivation of Foot-and-Mouth Disease Virus Vaccine Strains by Activation of Virus-associated Endonuclease

References

1. Anderson E. C., Capstick P. B., Mowat G. N., Leech F. B. 1970; In vitro method for safety testing of foot and mouth disease vaccines. Journal of Hygiene 68:159–172
   [Google Scholar]
2. Bachrach H. L., Vande Woude G. F. 1968; Amino acid composition and C-terminal sequence of foot and mouth disease virus protein. Virology 34:282–289
   [Google Scholar]
3. Bachrach H. L., Moore D. M., McKercher P. D., Polatnick J. 1975; Immune and antibody responses to an isolated capsid protein of FMDV. Journal of Immunology 115:1636–1641
   [Google Scholar]
4. Bittle J. L., Houghten R. A., Alexander H., Shinnik T. M., Sutcliffe J. G., Lerner R. A., Rowlands D. J., Brown F. 1982; Protection against foot-and-mouth disease by immunisation with a chemically synthesised peptide predicted from the viral nucleotide sequence. Nature, London 298:30–33
   [Google Scholar]
5. Boothroyd J. C., Highfield P. E., Cross G. A. M., Rowlands D. J., Lowe P. A., Brown F., Harris T. J. R. 1981; Molecular cloning of foot and mouth disease virus genome and nucleotide sequences in the structural protein genes. Nature, London 290:800–802
   [Google Scholar]
6. Brown F., Wild T. F. 1966; The effect of heat on the structure of foot-and-mouth disease virus and the viral ribonucleic acid. Biochimica et biophysica acta 119:301–308
   [Google Scholar]
7. Denoya C. D., Scodeller E. A., Vasquez C., La Torre J. L. 1978a; Ribonuclease activities associated with purified foot-and-mouth disease virus. Archives of Virology 57:153–159
   [Google Scholar]
8. Denoya C. D., Scodeller E. A., Vasquez C., La Torre J. L. 1978b; Foot-and-mouth disease virus. II Endoribonuclease activity within purified virions. Virology 89:67–74
   [Google Scholar]
9. Doel T. R., Baccarini P. J. 1981; Thermal stability of foot-and-mouth disease virus. Archives of Virology 70:21–32
   [Google Scholar]
10. Esionov A. V., Nikitin E. E. 1967; A comparative study of the immunogenic properties of ‘alkaline’ thermovaccine against the A variant of FMD. Aktualinye voprosy195–196
    [Google Scholar]
11. Graves J. H., Arlinghaus R. B. 1968; Acetylethyleneimine in the preparation of inactivated foot-and-mouth disease vaccine. Proceedings of the Meeting of the V.S. Livestock Sanitary Association 71:396–403
    [Google Scholar]
12. King A. M. Q., Underwood B. O., McCahon D., Newman J. W. L., Brown F. 1981; Biochemical identification of the virus causing the 1981 outbreak of foot-and-mouth disease virus in Britain. Nature, London 293:479–480
    [Google Scholar]
13. Kleid D. G., Yansura D., Small B., Dowbenko D., Moore D. M., Grubman M. V., McKercher P. D., Morgan D. O., Robertson B. H., Bachrach H. L. 1981; Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine. Science 214:1125–1129
    [Google Scholar]
14. Kupper H., Keller W., Kurz C., Porss S., Schaller H., Franze R., Strohmaier K., Marquardt O., Zaslavsky V. G., Hofschneider P. H. 1981; Cloning of CDNA of major antigen of foot-and-mouth disease virus and expression in E. coli. Nature, London 289:555–559
    [Google Scholar]
15. Laemmli U. K. 1970; Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, London 211:680–685
    [Google Scholar]
16. Moosbrugger G. A. 1948; Recherches experimentales sur la Fievre Aphteuse. Schweizer Archivfür Tierheilkunde 90:176–178
    [Google Scholar]
17. Perry R. P., La Torre J. L., Kelley D. E., Greenberg J. R. 1972; On the lability of poly(A) sequences during extraction of messenger RNA from polyribosomes. Biochimica et biophysica acta 262:220–226
    [Google Scholar]
18. Schneider B. 1955; Pathogenicity of adsorbed vaccines against foot-and-mouth disease. Monatshefte für Tierheilkunde 7:81–87
    [Google Scholar]
19. Ward R. L. 1978; Mechanism of poliovirus inactivation by ammonia. Journal of Virology 26:299–305
    [Google Scholar]
20. Wild T. F., Brown F. 1968; A study of the physical properties of the immunising antigen of FMD virus and the effect of various inactivating agents on its structure. Archiv für die gesamte Virusforschung 24:86–103
    [Google Scholar]